# Sim&Cure

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sim-cure

- Industry: Medical Devices & Equipment
- Headquarters: Montpellier, France
- Website: www.sim-and-cure.com
- Total disclosed funding: $10M
- Latest round: Series A (Nov 28, 2025)
- Investors on record: 7

## About

Sim&Cure, SA develops advanced solutions utilizing Digital Twin and AI technologies to significantly improve the treatment of brain aneurysms and enhance procedural success in neurovascular interventions.Founded in 2014 in France, Sim&Cure, SA focuses on innovative solutions for treating brain aneurysms. The company has engaged in three deals, with the most recent being a Series A funding round on November 28, 2025, raising EUR 2.3 mn led by Elaia Partners with participatopn from IT-Translation, Irdi Capital Investissement, SWEN Capital Partners, Sofilaro, Tudigo, and Holnest. Mathieu Sanchez serves as both the founder and CEO, leading the company's strategic direction.Sim&Cure specializes in advanced solutions for brain aneurysm treatment, leveraging Digital Twin and AI technologies to improve patient care. Their core offerings include sophisticated tools designed to support endovascular procedures critical for aneurysm treatment. These solutions enhance healthcare professionals' capabilities to optimize patient outcomes during interventions, serving hospitals, clinics, and neurovascular specialists globally, with a significant presence in North America, Europe, and parts of Asia-Pacific.In 2020, Sim&Cure reported revenue of EUR 1,249,270.20 with an EBITDA of EUR -964,853.30. The revenue generation model is primarily B2B, involving direct sales to healthcare institutions and medtech companies, as well as subscription models for software updates and support services.With the recent Series A funding of EUR 2.3 mn raised on November 28, 2025, Sim&Cure plans to expand into Asia-Pacific including China, speed up development of its neurovascular simulation software, and grow its R&D and sales teams.

## Funding rounds

- Series A, Nov 28, 2025, $2.7M — Elaia Partners, SWEN Capital Partners, Irdi Capital Investissement, IT-Translation, Sofilaro, Holnest, Tudigo
- Series A, Sep 22, 2023, $4M — Elaia Partners, IT-Translation
- Series A, Mar 13, 2020, $3.3M — Elaia Partners, IT-Translation

## Investors

- Elaia Partners (https://capitalatlas.ai/funds/elaia-partners) — Series A
- IT-Translation (https://capitalatlas.ai/funds/it-translation) — Series A
- SWEN Capital Partners (https://capitalatlas.ai/funds/swen-capital-partners) — Series A
- Irdi Capital Investissement (https://capitalatlas.ai/funds/irdi-capital-investissement) — Series A
- Sofilaro (https://capitalatlas.ai/funds/sofilaro) — Series A
- Holnest — Series A
- Tudigo — Series A